South Africa is expected to resume the use of the Johnson & Johnson vaccine to immunise healthcare workers soon, a move that is expected to bring stability in the markets as Covid-19 cases are on the rise. (Photo by JUSTIN TALLIS / AFP)
SA resumption of vaccine drive expected to stabilise market
By Siphelele Dludla
Share
JOHANNESBURG - SOUTH Africa is expected to resume the use of the Johnson & Johnson vaccine to immunise healthcare workers soon, a move that is expected to bring stability in the markets as Covid-19 cases are on the rise.
Confidence in the global economic recovery has been rising due to the success of vaccination roll-outs in various countries with investors in South African markets keeping a keen eye on the speed of vaccine delivery as well as the virus infection rate.